Ronald M. Nordmann
President chez Global Health Associates LLC
Profil
Ronald M.
Nordmann currently works at AgeneBio, Inc., as Director from 2013, American Red Cross, Inc., as Director, The Johns Hopkins University, as Trustee-Emeritus, and Global Health Associates LLC, as Co-President from 2000.
Mr. Nordmann also formerly worked at Endo Generics Holdings, Inc., as Independent Director from 2001 to 2012, Roberts Pharmaceutical Corp., as Non-Executive Director, Guilford Pharmaceuticals, Inc., as Director, Shire Plc, as Non-Executive Director from 1999 to 2008, BELLUS Health, Inc., as Director, PaineWebber, Inc., as Managing Director, Deerfield Management Co. LP, as Partner from 1994 to 2000, Oppenheimer & Co., Inc., as Senior Vice President, Warner Chilcott Ltd., as Vice President, The Wall Street Journal, Inc., as Financial Analyst, and F.
Eberstadt & Co., Inc., as Vice President.
Mr. Nordmann received his Masters Business Admin degree from Fairleigh Dickinson University and undergraduate degree from The Johns Hopkins University.
Postes actifs de Ronald M. Nordmann
| Sociétés | Poste | Début |
|---|---|---|
| Global Health Associates LLC | President | 01/10/2000 |
| The Johns Hopkins University | Directeur/Membre du Conseil | - |
AgeneBio, Inc.
 AgeneBio, Inc. BiotechnologyHealth Technology AgeneBio, Inc. develops an innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function. It research focused on cognitive neuroscience and the neurobiology of the aging brain with most advanced clinical program targets amnestic mild cognitive impairment (aMCI), the symptomatic, pre-dementia stage of Alzheimer’s. The company was founded by Michela Gallagher in 2008 and is headquartered in Baltimore, MD. | Directeur/Membre du Conseil | 01/09/2013 |
American Red Cross, Inc.
 American Red Cross, Inc. Services to the Health IndustryHealth Services American Red Cross, Inc. provides individual and family social services. It is a humanitarian organization led by volunteers and guided by its Congressional Charter and the Fundamental Principles of the International Red Cross Movement, will provide relief to victims of disaster and help people prevent, prepare for, and respond to emergencies. The company was founded in 1881 and is headquartered in Kansas City, MO. | Directeur/Membre du Conseil | - |
Anciens postes connus de Ronald M. Nordmann
| Sociétés | Poste | Fin |
|---|---|---|
| PAR PHARMACEUTICAL COMPANIES, INC. | Directeur/Membre du Conseil | 28/09/2012 |
Shire Plc /Old/
 Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Directeur/Membre du Conseil | 23/05/2008 |
| BELLUS HEALTH | Directeur/Membre du Conseil | 18/08/2006 |
Guilford Pharmaceuticals, Inc.
 Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Directeur/Membre du Conseil | 03/10/2005 |
Deerfield Management Co. LP
 Deerfield Management Co. LP Investment ManagersFinance Deerfield Management Co. LP (Deerfield) is a SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Peter Drake in 1994. They are wholly owned by James E. Flynn and are controlled by its general partner, Flynn Management LLC. Deerfield provides discretionary investment management services in the healthcare sector to domestic and offshore private pooled investment vehicles and their related alternative investment vehicles. | Corporate Officer/Principal | 01/01/2000 |
Formation de Ronald M. Nordmann
| The Johns Hopkins University | Undergraduate Degree |
| Fairleigh Dickinson University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Endo Generics Holdings, Inc.
 Endo Generics Holdings, Inc. Pharmaceuticals: GenericHealth Technology Endo Generics Holdings, Inc. develops, manufactures, and markets generic pharmaceutical products. It also offers dosage, branded, and generic sterile injectable products. The company was founded in 1978 and is headquartered in New York, NY. | Health Technology |
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Health Technology |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Commercial Services |
Roberts Pharmaceutical Corp.
 Roberts Pharmaceutical Corp. Pharmaceuticals: OtherHealth Technology Roberts Pharmaceutical Corp. provides pharmaceutical products. It offers medicines for cardiovascular, gynecology. The company is headquartered in Eatontown, NJ. | Health Technology |
| PaineWebber, Inc. | Finance |
Oppenheimer & Co., Inc.
 Oppenheimer & Co., Inc. Investment ManagersFinance Oppenheimer & Co., Inc. provides security brokerage services. It also offers investment banking and advice to high net worth investors, individuals, businesses and institutions. The company is headquartered in New York, NY. | Finance |
BELLUS Health, Inc.
 BELLUS Health, Inc. Pharmaceuticals: MajorHealth Technology BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada. | Health Technology |
| Global Health Associates LLC | |
Deerfield Management Co. LP
Deerfield Management Co. LP Investment ManagersFinance Deerfield Management Co. LP (Deerfield) is a SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Peter Drake in 1994. They are wholly owned by James E. Flynn and are controlled by its general partner, Flynn Management LLC. Deerfield provides discretionary investment management services in the healthcare sector to domestic and offshore private pooled investment vehicles and their related alternative investment vehicles. | Finance |
| F. Eberstadt & Co., Inc. | |
Warner Chilcott Ltd.
 Warner Chilcott Ltd. Pharmaceuticals: MajorHealth Technology Warner Chilcott Ltd. develops and provides pharmaceutical products. It focuses on the women’s healthcare and dermatology segment. The company was founded in 1996 and headquartered in Hamilton, Bermuda. | Health Technology |
AgeneBio, Inc.
AgeneBio, Inc. BiotechnologyHealth Technology AgeneBio, Inc. develops an innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function. It research focused on cognitive neuroscience and the neurobiology of the aging brain with most advanced clinical program targets amnestic mild cognitive impairment (aMCI), the symptomatic, pre-dementia stage of Alzheimer’s. The company was founded by Michela Gallagher in 2008 and is headquartered in Baltimore, MD. | Health Technology |
American Red Cross, Inc.
American Red Cross, Inc. Services to the Health IndustryHealth Services American Red Cross, Inc. provides individual and family social services. It is a humanitarian organization led by volunteers and guided by its Congressional Charter and the Fundamental Principles of the International Red Cross Movement, will provide relief to victims of disaster and help people prevent, prepare for, and respond to emergencies. The company was founded in 1881 and is headquartered in Kansas City, MO. | Health Services |
The Wall Street Journal, Inc.
 The Wall Street Journal, Inc. Publishing: NewspapersConsumer Services The Wall Street Journal, Inc. publishes newspapers and periodicals. It covers international business, financial news, and issues of the United States. The company was established in 1889 and is headquartered in New York, NY. | Consumer Services |